Showing results (81-90 of 104) with videos related to
Sort By:
Pageof 11
Blood|March 1, 1994
BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell deathA McGahon, R Bissonnette, M Schmitt, et al.The Journal of Biological Chemistry|January 16, 1999
Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xLD M Finucane, E Bossy-Wetzel, N J Waterhouse, et al.Leukemia|April 14, 2000
Sensitisation of HL60 human leukaemic cells to cytotoxic drug-induced apoptosis by inhibition of PI3-kinase survival signalsD M O'Gorman, S L McKenna, A J McGahon, et al.Leukemia|June 1, 1996
The repression of apoptosis by activated abl oncogenes in chronic myelogenous leukaemiaR S Fernandes, A M Gorman, A McGahon, et al.Leukemia & Lymphoma|June 1, 1996
Morphologic evidence of apoptosis in childhood acute myeloblastic leukemia treated with high-dose methylprednisoloneG Hiçsönmez, E Erdemli, M Tekelioglu, et al.FEBS Letters|September 2, 1996
Reactive oxygen intermediate(s) (ROI): common mediator(s) of poly(ADP-ribose)polymerase (PARP) cleavage and apoptosisA J McGowan, M C Ruiz-Ruiz, A M Gorman, et al.Experimental Cell Research|August 10, 1999
Collapse of the inner mitochondrial transmembrane potential is not required for apoptosis of HL60 cellsD M Finucane, N J Waterhouse, G P Amarante-Mendes, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 27, 2016
Effects of surgery on the cancer stem cell nicheD P O'Leary, E O'Leary, N Foley, et al.British Journal of Cancer|May 13, 2004
The anticancer drug mithramycin A sensitises tumour cells to apoptosis induced by tumour necrosis factor (TNF)V Duverger, A-M Murphy, D Sheehan, et al.Science (New York, N.Y.)|July 10, 1992
Role for c-myc in activation-induced apoptotic cell death in T cell hybridomasY Shi, J M Glynn, L J Guilbert, et al.Pageof 11